Search

Your search keyword '"Inoue, Shogo"' showing total 503 results

Search Constraints

Start Over You searched for: Author "Inoue, Shogo" Remove constraint Author: "Inoue, Shogo"
503 results on '"Inoue, Shogo"'

Search Results

52. CD44 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma

53. Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor

55. P53 Is Involved in Sunitinib Resistance and Poor Progression-free Survival After Sunitinib Treatment of Renal Cell Carcinoma

58. Tumor contact length of prostate cancer determined by a three‐dimensional method on multiparametric magnetic resonance imaging predicts extraprostatic extension and biochemical recurrence

60. Analysis and suppression of side radiation in leaky SAW resonators

61. [Corrigendum] Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy

65. Low-coherence interferometer system for the simultaneous measurement of refractive index and thickness

67. BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma

72. Recurrence‐ and progression‐free survival in intermediate‐risk non‐muscle‐invasive bladder cancer: the impact of conditional evaluation and subclassification

77. MP70-19 MAGNETIC RESONANCE IMAGING-TRANSRECTAL ULTRASOUND IMAGE FUSION BIOPSIES IMPROVED ACCURATE IDENTIFICATION OF THE INDEX TUMOR AT RADICAL PROSTATECTOMY SPECIMENS

79. MP18-18 P53 IS INVOLVED IN RESISTANCE TO SUNITINIB IN RENAL CELL CARCINOMA

80. MP82-03 CLINICOPATHOLOGICAL CHARACTERISTICS OF UPPER TRACT UROTHELIAL CANCER WITH LOSS OF IMMUNOHISTOCHEMICAL EXPRESSION OF MISMATCH REPAIR PROTEINS IN UNIVERSAL SCREENING

91. PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma

92. Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy

94. Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors

96. TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma

100. Magnetic resonance imaging/transrectal ultrasonography fusion targeted prostate biopsy finds more significant prostate cancer in biopsy‐naïve Japanese men compared with the standard biopsy

Catalog

Books, media, physical & digital resources